Translational research in immune senescence: Assessing the relevance of current models

Seminars in Immunology

Volumn 24, Issue 5, 2012, Pages 373-382

  High, Kevin P ^a   Akbar, Arne N ^b   Nikolich Zugich, Janko ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Immune senescence; Translational research

Indexed keywords

ACUTE DISEASE; ATHEROSCLEROSIS; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; DEATH; DEMENTIA; DISABILITY; DISEASE COURSE; DISEASE MODEL; FIBROBLAST; GERIATRIC DISORDER; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOLOGY; LYMPHOCYTE DIFFERENTIATION; NERVE CELL; NONHUMAN; PHENOTYPE; PREMATURE AGING; REVIEW; TRANSLATIONAL RESEARCH; VIRAL CLEARANCE; VIRUS INFECTION;

AGING; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MODELS, IMMUNOLOGICAL; TRANSLATIONAL MEDICAL RESEARCH; VIRUS DISEASES;

EID: 84868212804     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.04.007     Document Type: Review

References (89)

1. cdc.gov.; 2011. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5816a2.htm.
2. census.gov.; 2011. http://www.census.gov/compendia/statab/cats/births_deaths_marriages_divorces/life_expectancy.html.
3. census.gov.; 2011. http://www.census.gov/hhes/www/disability/disability.html.
4. Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. New England Journal of Medicine 2004, 351:2611-2618.
5. Akbar A.N., Henson S.M. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity. Nature Reviews Immunology 2011, 11:289-295.
6. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nature Reviews Immunology 2008, 8:512-522.
7. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
8. Vallejo A.N., Mueller R.G., Hamel D.L., Way A., Dvergsten J.A., Griffin P., et al. Expansions of NK-like alphabetaT cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells. Ageing Research Reviews 2011, 10:354-361.
9. Weng N.P., Akbar A.N., Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends in Immunology 2009, 30:306-312.
10. Brunner S., Herndler-Brandstetter D., Weinberger B., Grubeck-Loebenstein B. Persistent viral infections and immune aging. Ageing Research Reviews 2011, 10:362-369.
11. Coppe J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annual Review of Pathology 2010, 5:99-118.
12. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al-Regaiey K., Su L., et al. Ink4a/Arf expression is a biomarker of aging. Journal of Clinical Investigation 2004, 114:1299-1307.
13. Coppe J.P., Rodier F., Patil C.K., Freund A., Desprez P.Y., Campisi J. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. Journal of Biological Chemistry 2011, 286:36396-36403.
14. Connoy A.C., Trader M., High K.P. Age-related changes in cell surface and senescence markers in the spleen of DBA/2 mice: a flow cytometric analysis. Experimental Gerontology 2006, 41:225-229.
15. Liu Y., Sanoff H.K., Cho H., Burd C.E., Torrice C., Ibrahim J.G., et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell 2009, 8:439-448.
16. Song Z., von Figura G., Liu Y., Kraus J.M., Torrice C., Dillon P., et al. Lifestyle impacts on the aging-associated expression of biomarkers of DNA damage and telomere dysfunction in human blood. Aging Cell 2010, 9:607-615.
17. Shiels P.G. Improving precision in investigating aging: why telomeres can cause problems. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2010, 65:789-791.
18. Vergel M., Marin J.J., Estevez P., Carnero A. Cellular senescence as a target in cancer control. Journal of Aging Research 2011, 2010:725365.
19. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes and Development 2010, 24:2463-2479.
20. Toussaint O., Weemaels G., Debacq-Chainiaux F., Scharffetter-Kochanek K., Wlaschek M. Artefactual effects of oxygen on cell culture models of cellular senescence and stem cell biology. Journal of Cellular Physiology 2011, 226:315-321.
21. Ogrunc M., di F.F. Never-ageing cellular senescence. European Journal of Cancer 2011, 47:1616-1622.
22. Lang A., Nikolich-Zugich J. Functional CD8 T cell memory responding to persistent latent infection is maintained for life. Journal of Immunology 2011, 187:3759-3768.
23. Cicin-Sain L., Sylwester A.W., Hagen S.I., Siess D.C., Currier N., Legasse A.W., et al. Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques. Journal of Immunology 2011, 187:1722-1732.
24. Akbar A.N., Soares M.V., Plunkett F.J., Salmon M. Differential regulation of CD8+ T cell senescence in mice and men. Mechanisms of Ageing and Development 2000, 121:69-76.
25. Fauce S.R., Jamieson B.D., Chin A.C., Mitsuyasu R.T., Parish S.T., Ng H.L., et al. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. Journal of Immunology 2008, 181:7400-7406.
26. DiMitri D., Azevedo R.I., Henson S.M., Libri V., Riddell N.E., Macaulay R., et al. Reversible senescence in human CD4+CD45RA+. Journal of Immunology 2011, 187:2093-2100.
27. Henson S.M., Macaulay R., Franzese O., Akbar A.N. Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade. Immunology 2012, 135:355-363. April.
28. Onyema OO, Njemini R, Bautmans I, Renmans W, De WM, Mets T. Cellular aging and senescence characteristics of human T-lymphocytes. Biogerontology, [Epub ahead of print].
29. Dock J.N., Effros R.B. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging and Disease 2011, 2:382-397.
30. Macaulay R, Akbar AN, Henson SM. The role of the T cell in age-related inflammation. Age (Dordrecht), [Epub ahead of print].
31. Larbi A., Franceschi C., Mazzatti D., Solana R., Wikby A., Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 2008, 23:64-74.
32. Maue A.C., Yager E.J., Swain S.L., Woodland D.L., Blackman M.A., Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends in Immunology 2009, 30:301-305.
33. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. Journal of Virology 2001, 75:12182-12187.
34. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. Journal of Immunology 2002, 168:5893-5899.
35. Xie D., McElhaney J.E. Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes. Mechanisms of Ageing and Development 2007, 128:392-400.
36. Trzonkowski P., Myśliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 2003, 21:3826-3836.
37. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mechanisms of Ageing and Development 2007, 128:92-105.
38. Wills M., Akbar A., Beswick M., Bosch J.A., Caruso C., Colonna-Romano G., et al. Report from the second cytomegalovirus and immunosenescence workshop. Immunity and Ageing 2011, 8:10.
39. Fulop T., Larbi A., Witkowski J.M., McElhaney J., Loeb M., Mitnitski A., et al. Aging, frailty and age-related diseases. Biogerontology 2010, 11:547-563.
40. Bruunsgaard H., Skinhoj P., Qvist J., Pedersen B.K. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. Journal of Infectious Diseases 1999, 180:551-554.
41. Cardenas J.C., Owens A.P., Krishnamurthy J., Sharpless N.E., Whinna H.C., Church F.C. Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:827-833.
42. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479:232-236.
43. Ageing Peeper D.S. Old cells under attack. Nature 2011, 479:186-187.
44. Liu Y., Johnson S.M., Fedoriw Y., Rogers A.B., Yuan H., Krishnamurthy J., et al. Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood 2011, 117:3257-3267.
45. Hein W.R., Griebel P.J. A road less travelled: large animal models in immunological research. Nature Reviews Immunology 2003, 3:79-84.
46. MacGregor R.R., Boyer J.D., Ugen K.E., Lacy K.E., Gluckman S.J., Bagarazzi M.L., et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. Journal of Infectious Diseases 1998, 178:92-100.
47. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. Journal of Immunology 2004, 172:2731-2738.
48. Barreiro L.B., Ben-Ali M., Quach H., Laval G., Patin E., Pickrell J.K., et al. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genetics 2009, 5:e1000562.
49. Copeland S., Warren H.S., Lowry S.F., Calvano S.E., Remick D. Acute inflammatory response to endotoxin in mice and humans. Clinical and Diagnostic Laboratory Immunology 2005, 12:60-67.
50. Munford R.S. Murine responses to endotoxin: another dirty little secret. Journal of Infectious Diseases 2010, 201:175-177.
51. Kipling D., Cooke H.J. Hypervariable ultra-long telomeres in mice. Nature 1990, 347:400-402.
52. Borthwick N.J., Lowdell M., Salmon M., Akbar A.N. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. International Immunology 2000, 12:1005-1013.
53. Hamann D., Baars P.A., Rep M.H., Hooibrink B., Kerkhof-Garde S.R., Klein M.R., et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. Journal of Experimental Medicine 1997, 186:1407-1418.
54. Baars P.A., Sierro S., Arens R., Tesselaar K., Hooibrink B., Klenerman P., et al. Properties of murine (CD8+). European Journal of Immunology 2005, 35:3131-3141.
55. Hodes R.J., Hathcock K.S., Weng N.P. Telomeres in T and B cells. Nature Reviews Immunology 2002, 2:699-706.
56. Valenzuela H.F., Effros R.B. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clinical Immunology 2002, 105:117-125.
57. Parham P., Abi-Rached L., Matevosyan L., Moesta A.K., Norman P.J., Older Aguilar A.M., et al. Primate-specific regulation of natural killer cells. Journal of Medical Primatology 2010, 39:194-212.
58. Clambey E.T., Kappler J.W., Marrack P. CD8 T cell clonal expansions & aging: a heterogeneous phenomenon with a common outcome. Experimental Gerontology 2007, 42:407-411.
59. Kohlmeier J.E., Connor L.M., Roberts A.D., Cookenham T., Martin K., Woodland D.L. Nonmalignant clonal expansions of memory CD8+ T cells that arise with age vary in their capacity to mount recall responses to infection. Journal of Immunology 2010, 185:3456-3462.
60. Lang A., Brien J.D., Messaoudi I., Nikolich-Zugich J. Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication. Journal of Immunology 2008, 180:4848-4857.
61. Messaoudi I., Warner J., Nikolich-Zugich J. Age-related CD8+ T cell clonal expansions express elevated levels of CD122 and CD127 and display defects in perceiving homeostatic signals. Journal of Immunology 2006, 177:2784-2792.
62. Messaoudi I., Warner J., Nikolich-Zugich D., Fischer M., Nikolich-Zugich J. Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo. Journal of Immunology 2006, 176:301-308.
63. Shultz L.D., Ishikawa F., Greiner D.L. Humanized mice in translational biomedical research. Nature Reviews Immunology 2007, 7:118-130.
64. Yajima M., Imadome K., Nakagawa A., Watanabe S., Terashima K., Nakamura H., et al. T cell-mediated control of Epstein-Barr virus infection in humanized mice. Journal of Infectious Diseases 2009, 200:1611-1615.
65. Bruce-Keller A.J., Gupta S., Knight A.G., Beckett T.L., McMullen J.M., Davis P.R., et al. Cognitive impairment in humanized APPxPS1 mice is linked to Abeta(1-42) and NOX activation. Neurobiology of Disease 2011, 44:317-326.
66. Warren H.S., Fitting C., Hoff E., Adib-Conquy M., Beasley-Topliffe L., Tesini B., et al. Resilience to bacterial infection: difference between species could be due to proteins in serum. Journal of Infectious Diseases 2010, 201:223-232.
67. Ohtsuka Y., Kobayashi K., Hirano T., Furukawa S., Nagano S., Takahashi T. Involvement of lipoproteins in suppression of interleukin 2-dependent cell proliferation by sera from aged humans. Gerontology 1990, 36:268-275.
68. Rivnay B., Bergman S., Shinitzky M., Globerson A. Correlations between membrane viscosity, serum cholesterol, lymphocyte activation and aging in man. Mechanisms of Ageing and Development 1980, 12:119-126.
69. Agius E., Lacy K.E., Vukmanovic-Stejic M., Jagger A.L., Papageorgiou A.P., Hall S., et al. Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. Journal of Experimental Medicine 2009, 206:1929-1940.
70. Vissinga C., Nagelkerken L., Zijlstra J., Hertogh-Huijbregts A., Boersma W., Rozing J. A decreased functional capacity of CD4+ T cells underlies the impaired DTH reactivity in old mice. Mechanisms of Ageing and Development 1990, 53:127-139.
71. Macatonia S.E., Knight S.C. Dendritic cells and T cells transfer sensitization for delayed-type hypersensitivity after skin painting with contact sensitizer. Immunology 1989, 66:96-99.
72. Vukmanovic-Stejic M., Rustin M.H., Nikolich-Zugich J., Akbar A.N. Immune responses in the skin in old age. Current Opinion in Immunology 2011, 23:525-531.
73. Cicin-Sain L., Smyk-Pearson S., Currier N., Byrd L., Koudelka C., Robinson T., et al. Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. Journal of Immunology 2010, 184:6739-6745.
74. Messaoudi I., Warner J., Fischer M., Park B., Hill B., Mattison J., et al. Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:19448-19453.
75. Jankovic V., Messaoudi I., Nikolich-Zugich J. Phenotypic and functional T-cell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets. Blood 2003, 102:3244-3251.
76. Austad S.N. Comparative biology of aging. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2009, 64:199-201.
77. Austad S.N., Fischer K.E. The development of small primate models for aging research. ILAR Journal 2011, 52:78-88.
78. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mechanisms of Ageing and Development 1984, 28:47-55.
79. Castle S.C., Uyemura K., Makinodan T. The SENIEUR protocol after 16 years: a need for a paradigm shift. Mechanisms of Ageing and Development 2001, 122:127-130.
80. Trzonkowski P., Mysliwska J., Pawelec G., Mysliwski A. From bench to bedside and back: the SENIEUR protocol and the efficacy of influenza vaccination in the elderly. Biogerontology 2009, 10:83-94.
81. Turnbull I.R., Wlzorek J.J., Osborne D., Hotchkiss R.S., Coopersmith C.M., Buchman T.G. Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock 2003, 19:310-313.
82. Girard T.D., Opal S.M., Ely E.W. Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clinical Infectious Diseases 2005, 40:719-727.
83. Boyd C.M., Ritchie C.S., Tipton E.F., Studenski S.A., Wieland D. From bedside to bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults. Aging Clinical and Experimental Research 2008, 20:181-188.
84. Turnbull I.R., Wlzorek J.J., Osborne D., Hotchkiss R.S., Coopersmith C.M., Buchman T.G., et al. Gerontologic biostatistics: the statistical challenges of clinical research with older study participants. Journal of the American Geriatrics Society 2010, 58:1386-1392.
85. Kirkland J.L., Peterson C. Healthspan, translation, and new outcomes for animal studies of aging. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2009, 64:209-212.
86. High K.P., Trader M., Pahor M., Loeb M. Intraindividual variability and the effect of acute illness on immune senescence markers. Journal of the American Geriatrics Society 2005, 53:1761-1766.
87. Davis M.M. A prescription for human immunology. Immunity 2008, 29:835-838.
88. Tacutu R., Budovsky A., Yanai H., Fraifeld V.E. Molecular links between cellular senescence, longevity and age-related diseases-a systems biology perspective. Aging (Albany, NY) 2011, 3:1178-1191.
89. Vallejo A.N., Hamel D.L., Mueller R.G., Ives D.G., Michel J.J., Boudreau R.M., et al. NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging. PLoS One 2011, 6:e26558.